Director and Principal Investigator
Dr. John M. Vierling, professor of medicine and surgery, chief of hepatology and director of Advanced Liver Therapies at ÌÇÐÄÊÓƵ of Medicine discusses Non-Alcoholic Fatty Liver Disease (NAFLD) risks, treatments and clinical trials.
John Moore Vierling
MD, FACP, FAASLD, AGAF
Professor of Medicine, Transplant Hepatology Medical Director
Staff
Eva Zimmerman
Clinical Research Regulatory Coordinator